Abstract

ObjectiveAppropriate use of antibiotics in the management of hospitalised patients with COPD exacerbations is defined within the GOLD strategy. This paper analyses the factors associated with antibiotic prescribing in patients to better understand how prescribing may be improved.MethodsThe European COPD audit was a study of clinical care in 384 hospitals from 13 European countries between 2010 and 2011 enrolling 16018 patients. Those admitted to hospital due to a clinician-made diagnosis of exacerbation of COPD at the time of discharge were audited. We defined antibiotic prescribing compliance as consistent with the GOLD 2010 recommendations. Two different multivariate models were used to evaluate factors associated with the prescription of antibiotics and the guideline-compliant prescriptions.ResultsOverall 86% of admissions were given antibiotics but only 61.4% cases met the GOLD recommendations. Antibiotics were more likely to be given in hospital and at discharge if received prior to admission. Antibiotic prescription was more likely in patients who met the GOLD recommendations and in those with radiological consolidation but there was also a significant use of antibiotics in patients who did not meet either criterion. Patients cared for on a Respiratory Ward were more likely to receive GOLD compliant antibiotic management.ConclusionsThe present study describes the audited in-hospital antibiotic prescription for COPD exacerbation across different European countries. In general, there is an apparent overuse of antibiotics likely to be associated with both patient and practice-related variables.

Highlights

  • Antibiotic prescription is one of the mainstay treatments for exacerbations of chronic obstructive pulmonary disease, a number of controversies are associated with the use of this therapy

  • Antibiotic prescription was more likely in patients who met the Global Initiative for Obstructive Lung Disease (GOLD) recommendations and in those with radiological consolidation but there was a significant use of antibiotics in patients who did not meet either criterion

  • The present study describes the audited in-hospital antibiotic prescription for chronic obstructive pulmonary disease (COPD) exacerbation across different European countries

Read more

Summary

Introduction

Antibiotic prescription is one of the mainstay treatments for exacerbations of chronic obstructive pulmonary disease, a number of controversies are associated with the use of this therapy. It is widely acknowledged that antibiotics should not be prescribed for all exacerbations, but only to those caused by a bacterial infection [1, 2]. The problem arises when there are no rapid culture tests than can confirm that a particular exacerbation is caused by a bacterial infection in the acute setting. The decision to prescribe antibiotics for exacerbation of chronic obstructive pulmonary disease (COPD) is currently based on clinical criteria, led mainly by the presence of purulent sputum [2, 6]. The Global Initiative for Obstructive Lung Disease (GOLD) strategy document makes evidenced recommendations for antibiotic indication in hospitalised patients admitted for management of COPD exacerbations [4] derived from the European guidelines for the management of lower respiratory tract infections [7]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call